Embodiments of the present disclosure relate to nasal and sinus devices. More specifically, embodiments of the disclosure relate to delivering an solution/substance to the nasal and sinus cavities.
Paranasal sinuses are cavities formed within the bones of the face that are accessible via an individual's nasal cavity. The paranasal sinuses include the frontal sinuses, the sphenoid sinuses, the ethmoid sinuses, and the maxillary sinuses. Sino-nasal anatomy includes bilateral inferior, middle and supreme turbinate and the midline nasal septum. The paranasal sinuses and nose are lined with mucous-producing respiratory epithelial tissue.
Normally, mucous produced by the linings of the sino-nasal sinuses slowly drains out of each sinus through an opening known as an ostium. Some conditions, however, can interfere with the drainage of the mucous. A healthy sino-nasal condition depends upon proper mucous drainage from the sinus cavities and the nose. When this natural process is disrupted by the effects of allergen, other bioactive particulate matter deposits or abnormal anatomic variations a condition of mucous stasis in the sinus cavities or the nose. As a consequence, nasal lining mucositis and/or sino-nasal disorders (e.g., a sinus infection, sinus headache, epistaxis, nasal obstruction, rhinorrhea) can result. Some of the conventional systemic approaches to treating these disorders often result in cutaneous rash, diarrhea, bacterial resistance from antibiotic use, adrenal suppression, weight gain from steroid medications, hypertension, sleep disturbance from decongestant use, epistaxis, headache, vertigo and others.
Surgery that is performed on the paranasal sinus cavities results in altered, modified or otherwise widened sinus drainage pathways compared to native outflow tracts.
Direct application of a substance to a sinus through a nasal cavity may avoid some of the side-effects listed above that are inherent in a systemic approach to treating sinusitis, rhinitis and/or mucositis.
However, due to the lateral or superior location of sinus outflow tracts the introduction of a substance via a trans-nasal route may result in a large majority of the substance bypassing the intended sinus cavity ostia.
More specifically, the post-surgical maxillary sinus ostia is located on the lateral nasal wall approximately 3.0 to 4.0 centimeters from the apex of the external nasal vestibule and approximately at a 45 degree angle with respect to the floor of the nose. Thus, a substance delivered using a device introduced into the nose at approximately 45 degrees from the floor of the nose with an approximate length of 3 to 4 centimeters and with the capability of directing a substance at an 80 to 90 degree angle relative to the device itself would have the capability of directly delivering a substance to the maxillary sinus cavity when properly oriented.
Additionally, the post-surgical frontal sinus outflow tract is located superiorly in the nasal cavity at approximately 5 to 6 centimeters from the apex of the external nasal vestibule at approximately 75° to 85° relative to the floor of the nose. Thus, a substance delivered using a device introduced into the nose at approximately 45 degrees from the floor of the nose with an approximate length of 3 to 4 centimeters and with the capability of directing a substance at an 80 to 90 degree angle relative to the device itself would have the capability of directly delivering a substance to the frontal sinus cavity when properly oriented.
Accordingly, there is a need for a device, system, and method of treatment that has the capability to quickly and accurately apply a substance directly to a laterally or superiorly located paranasal sinus outflow tract. The present disclosure discusses a device that satisfies such needs, among the others delineated.
Direct application of a substance to an infected sinus through a nasal cavity will avoid some of the side-effects listed above that are inherent in a systemic approach. However, the introduction of a substance via a trans-nasal route may result in a large majority of the substance flowing down the individual's throat, resulting in possible aspiration, coughing and or choking; if the substance enters the oral cavity it also is distasteful, which further exacerbates the unpleasantness. Additionally, if a substance is forcibly introduced into a nasal cavity it is possible to overcome physiologic proximal Eustachian tube resistance resulting in the substance contaminating the middle-ear. The presence of a substance (other than physiologic body-temperature aeration) in the middle-ear may result in aural fullness, otitis effusion, otitis media, hearing loss (possibly permanent), ossicular chain injury, damage to the middle-ear mucosal lining, dizziness/unsteadiness, nystagmus, nausea and others.
Accordingly, there is a need for a device and/or system that has the capability to quickly and accurately apply a substance to a paranasal sinus and/or sino-nasal cavity, prevent the substance applied to a paranasal sinus and/or sino-nasal cavity from flowing down a patient's throat and/or prevent the substance from contaminating the middle-ear cavity. The present disclosure discusses a device that satisfies such needs, among the others delineated.
Agents used in medicated sinus lavage are commonly supplied in capsule or other form; many individuals with dexterity problems are unable to manage the delivery of medication supplied in capsule or other form into sinus irrigation solution.
With respect to solubility of agents administered as a sinus lavage, there exist a category of agents that are immiscible in an aqueous or saline environment therefore presenting a challenge to delivery of a consistent agent concentration.
The use of saline or other sino-nasal irrigation solution delivered in a non-linear, turbulent, or pulsatile manner provides potentially additional cleansing properties over a solution delivered as a constant, uniform stream.
The effective use of gravity-assist sino-nasal lavage can be limited by an inability to control the flow of irrigation solution due to the siphon effect, i.e. a tube used to convey liquid upwards from a reservoir and then flows down to a lower level due to gravity, once the liquid has been forced into the tube and elevated, flow continues unaided and cannot easily be controlled or stopped.
The effective use of gravity-assist sino-nasal lavage can be further limited by an inability to extend the neck and look upwards, as is required in the application of conventional sino-nasal irrigation systems that rely on gravity to dispense the solution. This limitation is particularly acute for persons with neck extension limitations or persons who experience dizziness in this position, in particular elderly persons.
Sino-nasal rinsing can be limited by design features that are selective for specific anatomy, specifically that of adult versus children.
Embodiments of the disclosure relate to delivering a pharmaceutically acceptable buffer preferably consisting of sterile saline solution or a solution with a therapeutically effective concentration of a pharmaceutical to nasal and sinus cavities. While multiple embodiments are disclosed, still other embodiments of the present disclosure will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the disclosure. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
The sino-nasal irrigation device consists of a reservoir container; a housing with a grinding chamber and nose piece; and an input apparatus with a mouth piece. The reservoir container is intended for holding an solution. The housing has a grinding chamber for crushing capsules, pills, and the like, with an integrated filter separating the grinding chamber and the reservoir container that allows ground material of a predetermined size to pass through the filter and into the reservoir container. The housing also has a nose piece with a nasal tip and an optional nasal tip extension.
When the sino-nasal irrigation device is assembled with a solution in the reservoir container, and inverted such that the reservoir container is above the input apparatus and the housing, the weight of the solution in the reservoir container pushes down on the diaphragm creating a negative pressure on the diaphragm. The weight of the solution on the diaphragm prevents air from entering the reservoir container and thus prevents solution from the reservoir container from flowing out through the nose piece. Applying a positive pressure to the bottom of the diaphragm causes the diaphragm to open and allows air to flow into the reservoir container. The air flowing into the reservoir container causes turbulence in the solution held in the reservoir container resulting in the mixing of the air and solution. The air flowing into the reservoir container also allows the solution in the reservoir container to flow out of the reservoir through the nose piece and into a user's nasal cavity. When the positive pressure on the bottom of the diaphragm is removed, the flow of liquid from the reservoir container stops.
The accompanying drawings are incorporated into and form a part of the specification to illustrate several examples of the present disclosure. These drawings, together with the description, explain the principles of the disclosure. The drawings simply illustrate preferred and alternative examples of how the disclosure may be made and used and are not to be construed as limiting the disclosure to only the illustrated and described examples. Further features and advantages will become apparent from the following, more detailed, description of the various aspects, embodiments, and configurations of the disclosure, as illustrated by the drawings referenced below.
Before any embodiments of the disclosure are explained in detail, it is to be understood that the disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The disclosure is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting.
While the disclosed subject matter is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the disclosure to the particular embodiments described. To the contrary, the disclosure is intended to cover all modifications, equivalents, and alternatives falling within the scope of the disclosure as defined by the appended claims.
The term “solution” as used herein means a liquid; water; a pharmaceutically acceptable buffer solution, preferably consisting of a saline solution and more preferably still a sterile saline solution; and, a solution with a therapeutically effective concentration of a pharmaceutical. The pharmaceutical compound portion of the solution may be a salt, solid, liquid, or a gas (including a vapor). The pharmaceutical compound may be selected form any of the biopharmaceutical classes of the Biopharmaceutical Classification System (BCS) where Class 1 has high permeability and high solubility to Class 4 which has low permeability to low solubility. The solution containing a pharmaceutical compound may be an unsaturated solution, a saturated solution, a supersaturated solution, a mixture of two or more substances that are not chemically combined, a homogenous solution, a heterogenous solution, a suspension, or an emulsion.
The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.
As the terms are used herein with respect to ranges of measurements (such as those described above), “about” and “approximately” may be used interchangeably, to refer to a measurement that includes the stated measurement and that also includes any measurements that are reasonably close to the stated measurement, but that may differ by a reasonably small amount such as will be understood, and readily ascertained, by individuals having ordinary skill in the relevant arts to be attributable to measurement error, differences in measurement and/or manufacturing equipment calibration, human error in reading and/or setting measurements, adjustments made to optimize performance and/or structural parameters in view of differences in measurements associated with other components, particular implementation scenarios, imprecise adjustment and/or manipulation of objects by a person or machine, and/or the like.
Although the term “block” may be used herein to connote different elements illustratively employed, the term should not be interpreted as implying any requirement of, or particular order among or between, various steps disclosed herein unless and except when explicitly referring to the order of individual steps. Additionally, a “set” or “group” of items (e.g. inputs, algorithms, data values, etc.) may include one or more items, and, similarly, a subset or subgroup of items may include one or more items.
The term “means” as used herein shall be given its broadest possible interpretation in accordance with 35 U.S.C. Section 112(f). Accordingly, a claim incorporating the term “means” shall cover all structures, materials, or acts set forth herein, and all of the equivalents thereof. Further, the structures, materials or acts and the equivalents thereof shall include all those described in the summary of the invention, brief description of the drawings, detailed description, abstract, and claims themselves.
Referring to
The reservoir container (110) in the preferred embodiment has a hollow interior cavity adapted to contain an solution and has a base (112). The reservoir container (110) has a curved sidewall (115) that extends substantially perpendicular to the base (112) to the open top (117) of the reservoir container (110) thereby defining the hollow interior cavity. The reservoir container (110) is adapted to removably engage the housing (120). In the preferred embodiment the reservoir container (110) has male threads (118) to threadingly mate with the housing (120). The reservoir container (110) may be of any shape or size including a round bulbous shape, a square or a rectangle.
The housing (120) is removable attachable to the reservoir container (110). In the preferred embodiment the housing (120) has female threads (124) to threadably mate with the reservoir container (110). The top of the housing (122) has a grinding chamber (125) and a nose piece aperture (140). The grinding chamber (125) has a sidewall (128) that is preferably curved and extending substantially perpendicular to the top of the housing (122). The grinding chamber (125) has a filter (135) at the base that is integrated into the housing top (122) consisting of a plurality of holes (138) that will allow ground material of a defined size and water or a solution to pass through the filter (135). The plurality of holes (138) may be of uniform size or varying size. In the preferred embodiment the plurality of holes (138) are of varying size ranging from ⅛th of an inch in diameter to 3/16th of an inch in diameter.
In an alternative preferred embodiment other substances including powders, liquids, gaseous and vapors may be introduced into the reservoir container (110) through the filter integrated into the grinding chamber (135) or by bypassing the grinding chamber (125) and introduced directly into the solution in the reservoir container (110). In an alternative preferred embodiment a vapor pod (not shown) may be removably attached to the air tube (180) so that when a user exhales into the mouth piece (185) on the input apparatus (170) air and vapor from the vapor pod creates a positive pressure in the air tube (180) and air and vapor passes through the diaphragm (190) and into the reservoir container (110) where the vapor mixes with and dissolves into the solution. The introduction of air and vapor into the reservoir container (110) displacing the solution held in the reservoir container (110) out the nose tube (150) through the nasal tip (160).
The grinding chamber (125) also has a plurality of grinding teeth (130) that extend substantially perpendicular to the filter (135). The plurality of grinding teeth (130) may be of either uniform size and shape or varied size and shape. In the preferred embodiment the plurality of grinding teeth (130) consist of a plurality of cured grinding teeth (131) spaced equal distantly in a circular pattern in the grinding chamber (125) and a plurality of wedge shaped grinding teeth (132) located within the circular pattern formed by the curved grinding teeth (131).
The nose tube (150) is attached to the nose piece aperture (140) in the housing top (122). In the preferred embodiment the nose piece aperture (140) is a curve-linear oval shape. The nose tube (150) is preferably substantially rigid and curved such that when the sino-nasal device (100) is inverted the mouth piece (185) is proximate a user's mouth then the distal end of the nose tube (150) is proximate a user's nose bench. The nose tube (150) has a removable nasal tip (160) at the distal end of the nose tube (150). The nasal tip (160) frictionally engages the nose tube (150) and thus is adjustable and may be positioned in a preferable location for each user. The nasal tip (160) may be removed from the nose tube (150) for cleaning or replacement. The nasal tip (160) has various sizes and shapes (160a-160c) to accommodate the customary nasal opening sizes of children (160a), adults (160b), and larger adults (160c).
An alternative preferred embodiment may include a nasal tip for directional flow (167) that frictionally engage the nose tube (150) or the nasal tip aperture opening (165) to provide for a more controlled and direction application of medicine and/or solution to a surgical site, wound, or by user preference. The nasal tip for directional flow (167) is preferably flexible with a blunt terminal end (168) with a plurality of aperture openings (169) proximate to the terminal end that are preferably 2 to 4 mm in length and more preferably 1 to 2 mm in length. The plurality of aperture openings (169) are preferably oval, but may also be substantially circular or substantially square in order to provide a desired flow rate of solution in a preferred direction. The nasal tip for directional flow (167) are preferably 1 to 4 cm length, and more preferably 1 to 2 cm length. The exposed length of nasal tip for directional flow (167) may also be controlled by how far the nasal tip for directional flow (167) is inserted on the nose tube (150), or alternatively, into the tip aperture opening (165) in order to maximize the delivery of medicine and/or solution to a surgical site, wound, or by preference of a user.
The input apparatus (170) is removably attached to the grinding chamber (125) on the housing (120). In the preferred embodiment the input apparatus (170) has a hollow interior cavity (177) that is threaded to connect to the exterior of the grinding chamber sidewall (128). When the input apparatus (170) is attached to the grinding chamber (125) the mouth piece (185) of the input device (170) should align with the nasal tip (160) of the housing (120) when assembled and closed. The input apparatus (170) is comprised of a mouth piece (185) that is frictionally attached to an air tube (180) so that the location of the mouth piece (185) may be configured in a preferred way for each user. The air tube (180) is also connected to the L-connector (175) of the input apparatus (170). In the preferred embodiment the air tube (180) connects in the center of the top of the L-connector (175) which is attached to the input apparatus (170). A diaphragm (190) is interposed at the terminal end of the air tube (180) where the air tube (180) connects to the input apparatus (170).
When the sino-nasal irrigation device is assembled with a solution in the reservoir container, the diaphragm (190) permits air into the reservoir container (110) when a positive pressure exists in the air tube (180) by allowing air to pass through the diaphragm (190). When a positive pressure does not exist in the air tube (180), then the diaphragm (190) prevents the flow of an solution in the reservoir container (110) from flowing pass the diaphragm (190) and out the input apparatus (170).
The mortar (200) has a first distal end (205) with a recess (210) containing a plurality of grinding teeth (205) and a second distal end (207) with a plurality of tines (prongs) (225) that are covered by a frictionally engaged cap (220). In the preferred embodiment the plurality of grinding teeth (215) in the recess (210) in the first distal end (205) consist of a plurality of curved grinding teeth (215) spaced equal distantly in a circular pattern in the recess (210) and a square pike grinding tooth (210) in the center of the recess (210). The second distal end (207) has a plurality of tines (225) that may be sized or of variable sizes. In the preferred embodiment, the size and placement of the tines (225) matches the aperture size and pattern of the plurality of holes (138) in the filter integrated into the bottom of the grinding chamber (135) to facility the cleaning of the grinding chamber (135) by dislodging any material caught in the integrated filter (135) by pushing the tines (225) into underside of the integrated filter (135) in the housing top (122).
Referring to
The base station (700) contains a logic engine that permits a user to input the desired temperature a user wants the solution in the reservoir container (610) warmed to. The temperature probe (730) takes a temperature reading, and then compares that temperature reading to the input temperature. If the temperature reading is below the input temperature, then the logic engine provides power to the base station heating sources (720) in order to raise the temperature of the solution to the input temperature. Once the solution reaches the input temperature, the logic engine may reduce power to the base station heating source (720) or turn the base station heating source off. The logic engine will continue to measure the temperature of the solution through the temperature probe (730) and apply heat as needed to maintain temperature. The temperature probe (730) is preferably a thermistor, thermocouple or similar temperature measuring probe. The base station heating source (720) is preferably resistive heating coils but may be any known heating source known to one of ordinary skill in the art.
The alternative preferred embodiment may also have indirect stirring means such as a magnetic stirrer consisting of one or more magnets in the base station and at least one magnet in the reservoir container that may be used to stir the solution to aid the dissolution of difficult to dissolve chemical compounds into solution.
The alternative preferred embodiment may also include an ultra-violate (UV) light source proximately located adjacent to the reservoir container (610) that will sterilize the water in the reservoir container (610).
The sino-nasal irrigation device (100) may be used by filling the reservoir container (110) with the desired amount of water. Preferably, and recommended, sterile water is used. Alternatively, denatured water may be used. The housing (120) is then removably engaged on the reservoir container (110).
Optionally, if a user wants to use an aqueous saline solution, then the user may place capsule(s) containing the equivalent of 2.4 grains of sodium chloride (NaCl) per 10 ounces of water into the grinding chamber (125) on the housing (120). Then, while firming holding the reservoir container (110), the user engages the first distal end (205) of the mortar (200) with the grinding chamber (125) containing the capsule to grind the capsule and its contents to sufficiently fine size to pass through the filter integrated into the bottom of the grinding chamber (135). Preferably, grinding of a capsule is achieved by twisting the mortar (200) in the grinding chamber (125) while applying downward pressure. Thereby allowing the ground capsule to form an solution in reservoir container (110). If the plurality of holes (138) in the filter (135) have become occluded with remnants of the capsule, then the plurality of holes (138) should be cleared by removing the housing (120) from the reservoir container (110) and pushing the tines (225) on the second distal end of the mortar (207) through plurality of holes from the underside of the integrated filer (135) in the housing top (122) to dislodge any material occluding the filter holes (135). The housing (120) is then removably engaged on the reservoir container (110). In an alternative preferred embodiment other substances including powders, liquids, gaseous and vapors may be introduced into the reservoir container (110) through the filter integrated into the grinding chamber (135) or by bypassing the grinding chamber (125) and directly into the substance into the reservoir container (110), thereby creating an solution.
The input apparatus (170) may then be removably engaged on the housing (120). The mouth piece (185) of the input apparatus (170) is aligned with the nasal tip (160) on the housing (120). The sino-nasal irrigation device (100) is then ready for treatment application.
The sino-nasal irrigation device (100) is then inverted such that the reservoir container (110) is above the input apparatus (170) and the housing (120), the weight of the solution in the reservoir container (110) pushes down on the diaphragm (190) creating a negative pressure on the diaphragm (190). The weight of the solution on the diaphragm (190) prevents air from entering the reservoir container (110) and thus prevents liquid from the reservoir container (110) from flowing out through the nose tube (150). Applying a positive pressure to the bottom of the diaphragm (190) causes the diaphragm to open and allows air to flow into the reservoir container (110). The air flowing into the reservoir container (110) causes turbulence in the solution held in the reservoir container resulting in the mixing of the air and solution. The air flowing into the reservoir container also allows the liquid in the reservoir container (110) to flow out of the reservoir (110) through the nose tube (150) and into a user's nasal cavity. When the positive pressure on the bottom of the diaphragm (190) is removed, the flow of liquid from the reservoir container (110) stops.
When a user, blows or exhales against resistance, the user's soft palate/uvula elevates and contacts the posterior wall of the oro/nasopharynx, thereby closing the choana. This normal physiologic process effectively creates temporary anatomic isolation of the nasal cavity from the oral cavity, distal airway and glottis/proximal trachea. As such, any fluid that is introduced into the user's sino-nasal cavity, as described herein, will remain contained within a user's sino-nasal cavity, being directed out the contralateral sino-nasal cavity, and not travel into the user's distal airway, glottis/superior trachea.
In an alternative preferred embodiment, a user blows or exhales against resistance to close the choana by blowing into the mouth piece (185) on the input apparatus (170), but the tube (180) is partially constrained allowing only a fraction of the air exhaled by the user to reach the reservoir container (110), or is fully constrained such that none of the air exhaled by the user reaches the reservoir container (110). When a positive pressure is detected in the tube (180) due to a user exhaling then a small pump (not shown) is activated to pump solution from the reservoir container (110) out the nose tube (150). When the positive pressure is removed, the pump is deactivated and the flow ceases. This alternative preferred embodiment may be used by those with compromised respiratory systems due to illness or other infirmity.
Referring to
The foregoing discussion has been presented for purposes of illustration and description. The foregoing is not intended to limit the disclosure to the form or forms disclosed herein. In the foregoing Summary for example, various features of the disclosure are grouped together in one or more aspects, embodiments, and/or configurations for the purpose of streamlining the disclosure. The features of the aspects, embodiments, and/or configurations of the disclosure may be combined in alternate aspects, embodiments, and/or configurations other than those discussed above. For example, the device(s) described in the present) disclosure may be used in conjunction with other medical devices. This method of disclosure is not to be interpreted as reflecting an intention that the claims require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed aspect, embodiment, and/or configuration. Thus, the following claims are hereby incorporated into this Detailed Description, which each claim standing on its own as a separate preferred embodiment of the disclosure.
Moreover, though the general description of the invention has included detailed description of one or more aspects, embodiments, and/or configurations and certain variations and modifications, other variations, combinations, and modifications are within the scope of this disclosure, e.g., as may be within the skill and knowledge of those in the art, after understanding the present disclosure. The intent is to obtain rights which include alternative aspects, embodiments, and/or configurations to the extent permitted, including alternate, inter-changeable and/or equivalent structures, functions, ranges or steps are disclosed herein, and without intending to publicly dedicate any patentable subject matter.
The present application claims the benefit of and priority to, under 35 U.S.C. § 119(e), U.S. Provisional Application Ser. No. 62/691,010 filed on Jun. 28, 2018 entitled “Sino-Nasal Rinse Delivery Device with Agitation, Flow-Control and Integrated Medication Management System”; U.S. Provisional Application Ser. No. 62/782,889 filed on Dec. 20, 2018 entitled “Sino-Nasal Apparatus and Delivery Method Using Choanal Blockade and Electronic Agent Vaporization”; and, U.S. Provisional Application Ser. No. 62/782,898 filed on Dec. 20, 2018 entitled “Eustachian Tube Dysfunction Treatment Method with Isolating, Incremental, Auto-Insufflation Pressure Generator”, which are hereby incorporated herein by reference in their entireties for all that they teach and for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
2434875 | Turnbull et al. | Jan 1948 | A |
2493326 | Trinder | Jan 1950 | A |
2847997 | Tibone | Aug 1958 | A |
2936760 | Gants | May 1960 | A |
3049125 | Kriwkowitsch | Aug 1962 | A |
3664330 | Deutsch | May 1972 | A |
3747595 | Grossan | Jul 1973 | A |
3766924 | Pidgeon | Oct 1973 | A |
3800788 | White | Apr 1974 | A |
3850176 | Gottschalk | Nov 1974 | A |
3903893 | Scheer | Sep 1975 | A |
4592357 | Ersek | Jun 1986 | A |
4606346 | Berg et al. | Aug 1986 | A |
4819619 | Augustine et al. | Apr 1989 | A |
4883465 | Brennan | Nov 1989 | A |
4886493 | Yee | Dec 1989 | A |
4887593 | Wiley et al. | Dec 1989 | A |
5024658 | Kozlov et al. | Jun 1991 | A |
5116311 | Lofstedt | May 1992 | A |
5189727 | Guerreri | Feb 1993 | A |
5193525 | Silverstein et al. | Mar 1993 | A |
5213115 | Zytkovicz et al. | May 1993 | A |
5215536 | Lampropoulos et al. | Jun 1993 | A |
5242400 | Blake et al. | Sep 1993 | A |
5370640 | Kolff | Dec 1994 | A |
5446070 | Mantelle | Aug 1995 | A |
5462553 | Dolgin | Oct 1995 | A |
5483951 | Frassica et al. | Jan 1996 | A |
5514128 | Hillsman et al. | May 1996 | A |
5531676 | Edwards et al. | Jul 1996 | A |
5534242 | Henry | Jul 1996 | A |
5546964 | Stangerup | Aug 1996 | A |
5599304 | Shaari | Feb 1997 | A |
5626553 | Frassica et al. | May 1997 | A |
5647847 | Lafontaine et al. | Jul 1997 | A |
5667476 | Frassica et al. | Sep 1997 | A |
5676635 | Levin | Oct 1997 | A |
5685822 | Harhen | Nov 1997 | A |
5718666 | Alarcon | Feb 1998 | A |
5735817 | Shantha | Apr 1998 | A |
5752971 | Rosenbluth et al. | May 1998 | A |
5792100 | Shantha | Aug 1998 | A |
5819727 | Linder | Oct 1998 | A |
5827177 | Oneda et al. | Oct 1998 | A |
5827224 | Shippert | Oct 1998 | A |
5858331 | Henry | Jan 1999 | A |
5876329 | Harhen | Mar 1999 | A |
6027478 | Katz | Feb 2000 | A |
6106496 | Arnissolle | Aug 2000 | A |
6174280 | Oneda et al. | Jan 2001 | B1 |
6190330 | Harhen | Feb 2001 | B1 |
6258101 | Blake et al. | Jul 2001 | B1 |
6322542 | Nilson et al. | Nov 2001 | B1 |
6350231 | Ailinger et al. | Feb 2002 | B1 |
6350465 | Jonnalagadda et al. | Feb 2002 | B1 |
6394093 | Lethi | May 2002 | B1 |
6413499 | Clay | Jul 2002 | B1 |
6432986 | Levin | Aug 2002 | B2 |
6461294 | Oneda et al. | Oct 2002 | B1 |
6491940 | Levin | Dec 2002 | B1 |
6529756 | Phan et al. | Mar 2003 | B1 |
6530881 | Ailinger et al. | Mar 2003 | B1 |
6579582 | Harhen et al. | Jun 2003 | B1 |
D478987 | Groenke et al. | Aug 2003 | S |
6607546 | Murken | Aug 2003 | B1 |
6669711 | Noda | Dec 2003 | B1 |
6677321 | Levin | Jan 2004 | B1 |
6693670 | Stark | Feb 2004 | B1 |
6715485 | Djupesland | Apr 2004 | B1 |
6733440 | Ailinger et al. | May 2004 | B2 |
6740030 | Martone et al. | May 2004 | B2 |
6758840 | Knox | Jul 2004 | B2 |
6770080 | Kaplan et al. | Aug 2004 | B2 |
6793661 | Hamilton et al. | Sep 2004 | B2 |
6822213 | Stark | Nov 2004 | B2 |
6853858 | Shalev | Feb 2005 | B2 |
6902535 | Eberhart et al. | Jun 2005 | B2 |
7025923 | Harhen et al. | Apr 2006 | B2 |
7056284 | Martone et al. | Jun 2006 | B2 |
7056287 | Taylor et al. | Jun 2006 | B2 |
7081097 | Martone et al. | Jul 2006 | B2 |
7112578 | Levin | Sep 2006 | B2 |
D530815 | Murphy et al. | Oct 2006 | S |
7117033 | Shalev et al. | Oct 2006 | B2 |
7120489 | Shalev et al. | Oct 2006 | B2 |
7131969 | Hovda et al. | Nov 2006 | B1 |
D534216 | Makower et al. | Dec 2006 | S |
7146209 | Gross et al. | Dec 2006 | B2 |
7169161 | Bonnette et al. | Jan 2007 | B2 |
7190998 | Shalev et al. | Mar 2007 | B2 |
D544602 | Hughett et al. | Jun 2007 | S |
7336309 | Stark | Feb 2008 | B2 |
7361168 | Makower et al. | Apr 2008 | B2 |
7377901 | Djupesland et al. | May 2008 | B2 |
7410480 | Muni et al. | Aug 2008 | B2 |
7419497 | Muni et al. | Sep 2008 | B2 |
7462175 | Chang et al. | Dec 2008 | B2 |
7500971 | Chang et al. | Mar 2009 | B2 |
7507200 | Okada | Mar 2009 | B2 |
7520876 | Ressemann et al. | Apr 2009 | B2 |
7559925 | Goldfarb et al. | Jul 2009 | B2 |
7561919 | Shalev et al. | Jul 2009 | B2 |
7636597 | Gross et al. | Dec 2009 | B2 |
7640062 | Shalev | Dec 2009 | B2 |
7641644 | Chang et al. | Jan 2010 | B2 |
7642563 | Kang et al. | Jan 2010 | B2 |
7645272 | Chang et al. | Jan 2010 | B2 |
7648367 | Makower et al. | Jan 2010 | B1 |
7654997 | Makower et al. | Feb 2010 | B2 |
7678099 | Ressemann et al. | Mar 2010 | B2 |
7684859 | Shalev et al. | Mar 2010 | B2 |
7704259 | Kaplan et al. | Apr 2010 | B2 |
7717933 | Becker | May 2010 | B2 |
7720521 | Chang et al. | May 2010 | B2 |
7727186 | Makower et al. | Jun 2010 | B2 |
7727226 | Chang et al. | Jun 2010 | B2 |
7729759 | Shalev et al. | Jun 2010 | B2 |
7740642 | Becker | Jun 2010 | B2 |
7749515 | Blumenfeld | Jul 2010 | B2 |
7753929 | Becker | Jul 2010 | B2 |
7753930 | Becker | Jul 2010 | B2 |
7771409 | Chang et al. | Aug 2010 | B2 |
7785315 | Muni et al. | Aug 2010 | B1 |
7799337 | Levin | Sep 2010 | B2 |
7803150 | Chang et al. | Sep 2010 | B2 |
7837672 | Intoccia | Nov 2010 | B2 |
7841337 | Djupesland | Nov 2010 | B2 |
7842062 | Keith et al. | Nov 2010 | B2 |
7854744 | Becker | Dec 2010 | B2 |
7877147 | Shalev et al. | Jan 2011 | B2 |
7879011 | Chang | Feb 2011 | B2 |
7879061 | Keith et al. | Feb 2011 | B2 |
7908000 | Shalev | Mar 2011 | B2 |
7918871 | Truitt et al. | Apr 2011 | B2 |
D640374 | Liu et al. | Jun 2011 | S |
D643115 | Gonzales et al. | Aug 2011 | S |
8010189 | Shalev | Aug 2011 | B2 |
8012084 | Machida | Sep 2011 | B2 |
8025635 | Eaton et al. | Sep 2011 | B2 |
8052693 | Shahoian | Nov 2011 | B2 |
8080000 | Makower et al. | Dec 2011 | B2 |
8088101 | Chang et al. | Jan 2012 | B2 |
8090433 | Makower et al. | Jan 2012 | B2 |
8100933 | Becker | Jan 2012 | B2 |
8114062 | Muni et al. | Feb 2012 | B2 |
8114113 | Becker | Feb 2012 | B2 |
8118757 | Morriss | Feb 2012 | B2 |
8123722 | Chang et al. | Feb 2012 | B2 |
8142422 | Makower et al. | Mar 2012 | B2 |
D658291 | Jenkins et al. | Apr 2012 | S |
8146400 | Goldfarb et al. | Apr 2012 | B2 |
8172828 | Chang et al. | May 2012 | B2 |
8182432 | Kim et al. | May 2012 | B2 |
8190389 | Kim et al. | May 2012 | B2 |
8192420 | Morriss et al. | Jun 2012 | B2 |
8224438 | Levin | Jul 2012 | B2 |
8229571 | Lorian et al. | Jul 2012 | B2 |
8231588 | Xia | Jul 2012 | B2 |
8241266 | Keith et al. | Aug 2012 | B2 |
8241641 | Blumenfeld | Aug 2012 | B2 |
8249700 | Clifford et al. | Aug 2012 | B2 |
8277478 | Drontle et al. | Oct 2012 | B2 |
8282667 | Drontle et al. | Oct 2012 | B2 |
8308709 | Chang | Nov 2012 | B2 |
8313520 | Barbut et al. | Nov 2012 | B2 |
8317816 | Becker | Nov 2012 | B2 |
8337454 | Eaton et al. | Dec 2012 | B2 |
8348969 | Keith et al. | Jan 2013 | B2 |
8360968 | Hadani | Jan 2013 | B2 |
8388600 | Eldredge | Mar 2013 | B1 |
8388642 | Muni et al. | Mar 2013 | B2 |
8412336 | Pless et al. | Apr 2013 | B2 |
8414473 | Jenkins et al. | Apr 2013 | B2 |
8425457 | John et al. | Apr 2013 | B2 |
8425488 | Clifford et al. | Apr 2013 | B2 |
8435290 | Clifford et al. | May 2013 | B2 |
8439687 | Morriss et al. | May 2013 | B1 |
8452392 | Morriss et al. | May 2013 | B2 |
D683852 | Gonzales et al. | Jun 2013 | S |
8480658 | Nakao | Jul 2013 | B1 |
8485199 | Morriss | Jul 2013 | B2 |
8486155 | McAlister et al. | Jul 2013 | B2 |
8550073 | Djupesland | Oct 2013 | B2 |
8568439 | Keith et al. | Oct 2013 | B2 |
8585728 | Keith et al. | Nov 2013 | B2 |
8585729 | Keith et al. | Nov 2013 | B2 |
8623043 | Keith et al. | Jan 2014 | B1 |
8636684 | Deem et al. | Jan 2014 | B2 |
8657846 | Keith et al. | Feb 2014 | B2 |
8690839 | Xia et al. | Apr 2014 | B2 |
8702626 | Kim et al. | Apr 2014 | B1 |
8715169 | Chang et al. | May 2014 | B2 |
8721591 | Chang et al. | May 2014 | B2 |
8740839 | Eaton et al. | Jun 2014 | B2 |
8740929 | Gopferich et al. | Jun 2014 | B2 |
8747389 | Goldfarb et al. | Jun 2014 | B2 |
8764709 | Chang et al. | Jul 2014 | B2 |
8764726 | Chang et al. | Jul 2014 | B2 |
8764729 | Muni et al. | Jul 2014 | B2 |
8764786 | Becker | Jul 2014 | B2 |
8777926 | Chang et al. | Jul 2014 | B2 |
8801670 | Drontle et al. | Aug 2014 | B2 |
8828041 | Chang et al. | Sep 2014 | B2 |
8834513 | Hanson et al. | Sep 2014 | B2 |
8852143 | Chang et al. | Oct 2014 | B2 |
8858551 | Naito | Oct 2014 | B2 |
8858586 | Chang et al. | Oct 2014 | B2 |
8858974 | Eaton et al. | Oct 2014 | B2 |
8864787 | Muni et al. | Oct 2014 | B2 |
8876794 | Xia | Nov 2014 | B2 |
8882795 | Drontle et al. | Nov 2014 | B2 |
8888686 | Drontle et al. | Nov 2014 | B2 |
8894614 | Muni et al. | Nov 2014 | B2 |
8905922 | Makower et al. | Dec 2014 | B2 |
8905980 | Xia | Dec 2014 | B2 |
8910629 | Djupesland et al. | Dec 2014 | B2 |
8915938 | Keith et al. | Dec 2014 | B2 |
8932276 | Morriss et al. | Jan 2015 | B1 |
8954149 | Shalev | Feb 2015 | B2 |
8956280 | Eversull et al. | Feb 2015 | B2 |
8961398 | Makower et al. | Feb 2015 | B2 |
8978647 | Djupesland et al. | Mar 2015 | B2 |
8986340 | Drontle et al. | Mar 2015 | B2 |
9010325 | Djupesland et al. | Apr 2015 | B2 |
D730515 | Shahidi Bonjar | May 2015 | S |
9038630 | Djupesland et al. | May 2015 | B2 |
D735848 | Dubuc et al. | Aug 2015 | S |
D736922 | Allen et al. | Aug 2015 | S |
9248266 | Chandler et al. | Feb 2016 | B2 |
D772406 | Sanso et al. | Nov 2016 | S |
D773644 | Djupesland | Dec 2016 | S |
9510743 | Chandler et al. | Dec 2016 | B2 |
9516995 | Chandler et al. | Dec 2016 | B2 |
9649456 | Djupesland et al. | May 2017 | B2 |
9694163 | Chandler et al. | Jul 2017 | B2 |
9757455 | Roberts et al. | Sep 2017 | B2 |
9839347 | Chandler et al. | Dec 2017 | B2 |
10112021 | Hafner | Oct 2018 | B2 |
20010002999 | Neuser et al. | Jun 2001 | A1 |
20010004644 | Levin | Jun 2001 | A1 |
20020010194 | Levin | Jan 2002 | A1 |
20020062119 | Zadno-Azizi | May 2002 | A1 |
20020161379 | Kaplan et al. | Oct 2002 | A1 |
20030120256 | Lary et al. | Jun 2003 | A1 |
20030133877 | Levin | Jul 2003 | A1 |
20030208249 | Chen | Nov 2003 | A1 |
20040064150 | Becker | Apr 2004 | A1 |
20040116958 | Gopferich et al. | Jun 2004 | A1 |
20040243172 | Hogle | Dec 2004 | A1 |
20050072430 | Djupesland | Apr 2005 | A1 |
20050080357 | Eberhart et al. | Apr 2005 | A1 |
20050113798 | Slater et al. | May 2005 | A1 |
20050124856 | Fujikura et al. | Jun 2005 | A1 |
20050228452 | Mourlas et al. | Oct 2005 | A1 |
20050240147 | Makower et al. | Oct 2005 | A1 |
20050245894 | Zadno-Azizi | Nov 2005 | A1 |
20050245906 | Makower et al. | Nov 2005 | A1 |
20050281751 | Levin | Dec 2005 | A1 |
20060004286 | Chang et al. | Jan 2006 | A1 |
20060004323 | Chang et al. | Jan 2006 | A1 |
20060063973 | Makower et al. | Mar 2006 | A1 |
20060095066 | Chang et al. | May 2006 | A1 |
20060106361 | Muni et al. | May 2006 | A1 |
20060155304 | Kaplan et al. | Jul 2006 | A1 |
20060161044 | Oneda et al. | Jul 2006 | A1 |
20060167439 | Kalser et al. | Jul 2006 | A1 |
20060189844 | Tien | Aug 2006 | A1 |
20060189847 | Yee et al. | Aug 2006 | A1 |
20060210605 | Chang et al. | Sep 2006 | A1 |
20070015964 | Eversull et al. | Jan 2007 | A1 |
20070020254 | Levin | Jan 2007 | A1 |
20070043327 | Knox | Feb 2007 | A1 |
20070073269 | Becker | Mar 2007 | A1 |
20070112257 | Hensler | May 2007 | A1 |
20070119451 | Wang et al. | May 2007 | A1 |
20070129705 | Trombley et al. | Jun 2007 | A1 |
20070129751 | Muni et al. | Jun 2007 | A1 |
20070135789 | Chang et al. | Jun 2007 | A1 |
20070142709 | Martone et al. | Jun 2007 | A1 |
20070167682 | Goldfarb et al. | Jul 2007 | A1 |
20070179518 | Becker | Aug 2007 | A1 |
20070208252 | Makower | Sep 2007 | A1 |
20070208301 | Evard et al. | Sep 2007 | A1 |
20070249896 | Goldfarb et al. | Oct 2007 | A1 |
20070250105 | Ressemann et al. | Oct 2007 | A1 |
20070260264 | Nobis et al. | Nov 2007 | A1 |
20070265618 | Long | Nov 2007 | A1 |
20070267011 | Deem et al. | Nov 2007 | A1 |
20070282305 | Goldfarb et al. | Dec 2007 | A1 |
20070293726 | Goldfarb et al. | Dec 2007 | A1 |
20070293727 | Goldfarb et al. | Dec 2007 | A1 |
20070293946 | Gonzales et al. | Dec 2007 | A1 |
20080004613 | Barbut et al. | Jan 2008 | A1 |
20080015472 | Ressemann et al. | Jan 2008 | A1 |
20080015540 | Muni et al. | Jan 2008 | A1 |
20080082045 | Goldfarb et al. | Apr 2008 | A1 |
20080097154 | Makower et al. | Apr 2008 | A1 |
20080097239 | Chang et al. | Apr 2008 | A1 |
20080097295 | Makower et al. | Apr 2008 | A1 |
20080097400 | Chang et al. | Apr 2008 | A1 |
20080097514 | Chang et al. | Apr 2008 | A1 |
20080097515 | Chang et al. | Apr 2008 | A1 |
20080097516 | Chang et al. | Apr 2008 | A1 |
20080103361 | Makower et al. | May 2008 | A1 |
20080103521 | Makower et al. | May 2008 | A1 |
20080119693 | Makower et al. | May 2008 | A1 |
20080125626 | Chang et al. | May 2008 | A1 |
20080125720 | Kim et al. | May 2008 | A1 |
20080132938 | Chang et al. | Jun 2008 | A1 |
20080154237 | Chang et al. | Jun 2008 | A1 |
20080154250 | Makower et al. | Jun 2008 | A1 |
20080172033 | Keith et al. | Jul 2008 | A1 |
20080183128 | Morriss et al. | Jul 2008 | A1 |
20080195041 | Goldfarb et al. | Aug 2008 | A1 |
20080208242 | Becker | Aug 2008 | A1 |
20080208243 | Becker | Aug 2008 | A1 |
20080215082 | Becker | Sep 2008 | A1 |
20080215083 | Becker | Sep 2008 | A1 |
20080228085 | Jenkins et al. | Sep 2008 | A1 |
20080234720 | Chang et al. | Sep 2008 | A1 |
20080243140 | Gopferich et al. | Oct 2008 | A1 |
20080262468 | Clifford et al. | Oct 2008 | A1 |
20080262505 | Shahoian | Oct 2008 | A1 |
20080262508 | Clifford et al. | Oct 2008 | A1 |
20080262509 | Clifford et al. | Oct 2008 | A1 |
20080262510 | Clifford | Oct 2008 | A1 |
20080269643 | Morriss | Oct 2008 | A1 |
20080275483 | Makower et al. | Nov 2008 | A1 |
20080279895 | Blumenfeld | Nov 2008 | A1 |
20080281156 | Makower et al. | Nov 2008 | A1 |
20080281300 | Morriss | Nov 2008 | A1 |
20080281349 | Becker | Nov 2008 | A2 |
20080287908 | Muni et al. | Nov 2008 | A1 |
20080293999 | Halahmi | Nov 2008 | A1 |
20080319424 | Muni et al. | Dec 2008 | A1 |
20090005763 | Makower et al. | Jan 2009 | A1 |
20090028923 | Muni et al. | Jan 2009 | A1 |
20090030274 | Goldfarb et al. | Jan 2009 | A1 |
20090054803 | Saadat et al. | Feb 2009 | A1 |
20090076331 | Konwitz et al. | Mar 2009 | A1 |
20090093823 | Chang et al. | Apr 2009 | A1 |
20090125046 | Becker | May 2009 | A1 |
20090156980 | Eaton et al. | Jun 2009 | A1 |
20090163848 | Morriss et al. | Jun 2009 | A1 |
20090163890 | Clifford et al. | Jun 2009 | A1 |
20090171301 | Becker | Jul 2009 | A1 |
20090181074 | Makower et al. | Jul 2009 | A1 |
20090187098 | Makower et al. | Jul 2009 | A1 |
20090198216 | Muni et al. | Aug 2009 | A1 |
20090214466 | Levin | Aug 2009 | A1 |
20090227900 | Kim et al. | Sep 2009 | A1 |
20090240112 | Goldfarb et al. | Sep 2009 | A1 |
20090240237 | Goldfarb et al. | Sep 2009 | A1 |
20090304802 | Djupesland et al. | Dec 2009 | A1 |
20090306588 | Nguyen et al. | Dec 2009 | A1 |
20090312696 | Copa et al. | Dec 2009 | A1 |
20090312745 | Goldfarb et al. | Dec 2009 | A1 |
20090318797 | Hadani | Dec 2009 | A1 |
20100010302 | Hadani | Jan 2010 | A1 |
20100016844 | Patel et al. | Jan 2010 | A1 |
20100030031 | Goldfarb et al. | Feb 2010 | A1 |
20100030113 | Morriss et al. | Feb 2010 | A1 |
20100030131 | Morriss et al. | Feb 2010 | A1 |
20100030187 | Xia | Feb 2010 | A1 |
20100030188 | Xia | Feb 2010 | A1 |
20100035805 | Hafner | Feb 2010 | A1 |
20100042046 | Chang et al. | Feb 2010 | A1 |
20100056867 | LaBombard et al. | Mar 2010 | A1 |
20100057048 | Eldredge | Mar 2010 | A1 |
20100076269 | Makower et al. | Mar 2010 | A1 |
20100081873 | Tanimura et al. | Apr 2010 | A1 |
20100099946 | Jenkins et al. | Apr 2010 | A1 |
20100100181 | Makower et al. | Apr 2010 | A1 |
20100105983 | Oneda et al. | Apr 2010 | A1 |
20100114066 | Makower et al. | May 2010 | A1 |
20100114184 | Degtyar et al. | May 2010 | A1 |
20100121308 | Muni et al. | May 2010 | A1 |
20100152730 | Makower et al. | Jun 2010 | A1 |
20100168511 | Muni et al. | Jul 2010 | A1 |
20100174138 | Chang et al. | Jul 2010 | A1 |
20100174196 | Ryan et al. | Jul 2010 | A1 |
20100174308 | Chang et al. | Jul 2010 | A1 |
20100179488 | Spiegel et al. | Jul 2010 | A1 |
20100179511 | Rajan et al. | Jul 2010 | A1 |
20100198135 | Morriss et al. | Aug 2010 | A1 |
20100198191 | Clifford et al. | Aug 2010 | A1 |
20100198247 | Chang et al. | Aug 2010 | A1 |
20100210901 | Makower et al. | Aug 2010 | A1 |
20100211005 | Edwards et al. | Aug 2010 | A1 |
20100211007 | Lesch et al. | Aug 2010 | A1 |
20100211140 | Barbut et al. | Aug 2010 | A1 |
20100217296 | Morriss et al. | Aug 2010 | A1 |
20100241068 | Chen | Sep 2010 | A1 |
20100241155 | Chang et al. | Sep 2010 | A1 |
20100256653 | Kaplan et al. | Oct 2010 | A1 |
20100268245 | Chang et al. | Oct 2010 | A1 |
20100274188 | Chang et al. | Oct 2010 | A1 |
20100274222 | Setliff et al. | Oct 2010 | A1 |
20100280626 | Shalon et al. | Nov 2010 | A1 |
20100282246 | Djupesland et al. | Nov 2010 | A1 |
20100286659 | Terrill et al. | Nov 2010 | A1 |
20100292765 | Etwil | Nov 2010 | A1 |
20100298640 | Oneda et al. | Nov 2010 | A1 |
20100298862 | Chang et al. | Nov 2010 | A1 |
20100305697 | Clifford et al. | Dec 2010 | A1 |
20100324483 | Rozenberg et al. | Dec 2010 | A1 |
20110004057 | Goldfarb et al. | Jan 2011 | A1 |
20110004058 | Oneda et al. | Jan 2011 | A1 |
20110004192 | Eaton et al. | Jan 2011 | A1 |
20110004194 | Eaton et al. | Jan 2011 | A1 |
20110015645 | Liu et al. | Jan 2011 | A1 |
20110015734 | Gonzales et al. | Jan 2011 | A1 |
20110020279 | Shantha | Jan 2011 | A1 |
20110054395 | O'Dea et al. | Mar 2011 | A1 |
20110060214 | Makower | Mar 2011 | A1 |
20110087192 | Uhland et al. | Apr 2011 | A1 |
20110098659 | Covello | Apr 2011 | A1 |
20110112512 | Muni et al. | May 2011 | A1 |
20110114087 | Djupesland et al. | May 2011 | A1 |
20110152838 | Xia | Jun 2011 | A1 |
20110160623 | Shalev | Jun 2011 | A1 |
20110160740 | Makower et al. | Jun 2011 | A1 |
20110208215 | Modesitt et al. | Aug 2011 | A1 |
20110224652 | Drontle et al. | Sep 2011 | A1 |
20110245765 | Jacobsen et al. | Oct 2011 | A1 |
20110288559 | Shahoian | Nov 2011 | A1 |
20110318345 | Djupesland | Dec 2011 | A1 |
20120010646 | Keith et al. | Jan 2012 | A1 |
20120017893 | Xia | Jan 2012 | A1 |
20120046607 | Syk | Feb 2012 | A1 |
20120053404 | Schreck et al. | Mar 2012 | A1 |
20120071715 | Beyar et al. | Mar 2012 | A1 |
20120071727 | Hanson et al. | Mar 2012 | A1 |
20120071824 | Chang et al. | Mar 2012 | A1 |
20120071856 | Goldfarb et al. | Mar 2012 | A1 |
20120071857 | Goldfarb et al. | Mar 2012 | A1 |
20120078118 | Jenkins et al. | Mar 2012 | A1 |
20120078377 | Gonzales et al. | Mar 2012 | A1 |
20120089028 | Hadani et al. | Apr 2012 | A1 |
20120090620 | Deutsch | Apr 2012 | A1 |
20120101343 | Duffy et al. | Apr 2012 | A1 |
20120116254 | Morriss | May 2012 | A1 |
20120128683 | Shantha | May 2012 | A1 |
20120136207 | Goldfarb et al. | May 2012 | A1 |
20120157968 | Eldredge et al. | Jun 2012 | A1 |
20120172751 | Levin | Jul 2012 | A1 |
20120172835 | Becker | Jul 2012 | A1 |
20120184983 | Chang et al. | Jul 2012 | A1 |
20120220923 | Morriss et al. | Aug 2012 | A1 |
20120221034 | Dinger et al. | Aug 2012 | A1 |
20120227457 | Kim et al. | Sep 2012 | A1 |
20120245419 | Makower et al. | Sep 2012 | A1 |
20120245456 | Kim et al. | Sep 2012 | A1 |
20120259215 | Gerrans et al. | Oct 2012 | A1 |
20120259216 | Gerrans et al. | Oct 2012 | A1 |
20120265094 | Goldfarb et al. | Oct 2012 | A1 |
20120277578 | Gunday et al. | Nov 2012 | A1 |
20120302825 | Schaeffer et al. | Nov 2012 | A1 |
20120310145 | Clifford et al. | Dec 2012 | A1 |
20120323214 | Shantha | Dec 2012 | A1 |
20130006055 | Goldfarb et al. | Jan 2013 | A1 |
20130018431 | Levin | Jan 2013 | A1 |
20130030458 | Drontle et al. | Jan 2013 | A1 |
20130041463 | Ressemann | Feb 2013 | A1 |
20130053644 | Smith et al. | Feb 2013 | A1 |
20130053822 | Fischell et al. | Feb 2013 | A1 |
20130053824 | Seiden et al. | Feb 2013 | A1 |
20130066358 | Nalluri et al. | Mar 2013 | A1 |
20130072958 | Ressemann et al. | Mar 2013 | A1 |
20130073015 | Rozenberg | Mar 2013 | A1 |
20130085472 | Shaari | Apr 2013 | A1 |
20130090544 | Clifford et al. | Apr 2013 | A1 |
20130096605 | Becker | Apr 2013 | A1 |
20130103023 | Monson et al. | Apr 2013 | A1 |
20130123833 | Lesch et al. | May 2013 | A1 |
20130130145 | Kaeding et al. | May 2013 | A1 |
20130158475 | Xia et al. | Jun 2013 | A1 |
20130165873 | Morriss et al. | Jun 2013 | A1 |
20130172852 | Chang | Jul 2013 | A1 |
20130184532 | Goldfarb et al. | Jul 2013 | A1 |
20130184568 | Muni et al. | Jul 2013 | A1 |
20130184574 | Newhauser et al. | Jul 2013 | A1 |
20130184683 | Chow et al. | Jul 2013 | A1 |
20130190678 | Andreas et al. | Jul 2013 | A1 |
20130197426 | Morriss et al. | Aug 2013 | A1 |
20130231529 | John et al. | Sep 2013 | A1 |
20130245608 | Muni et al. | Sep 2013 | A1 |
20130245609 | Schaeffer et al. | Sep 2013 | A1 |
20130261388 | Jenkins et al. | Oct 2013 | A1 |
20130274600 | Jenkins et al. | Oct 2013 | A1 |
20130274651 | Barbut et al. | Oct 2013 | A1 |
20130274715 | Chan et al. | Oct 2013 | A1 |
20130276794 | Morriss | Oct 2013 | A1 |
20130281982 | Makower et al. | Oct 2013 | A1 |
20130302445 | Barbut et al. | Nov 2013 | A1 |
20130303968 | Clifford et al. | Nov 2013 | A1 |
20130324970 | Arcand et al. | Dec 2013 | A1 |
20130325052 | Chang et al. | Dec 2013 | A1 |
20140012182 | Shantha | Jan 2014 | A1 |
20140018775 | Swords et al. | Jan 2014 | A1 |
20140030520 | Nakamura et al. | Jan 2014 | A1 |
20140031726 | Chernomorsky et al. | Jan 2014 | A1 |
20140031792 | Darin et al. | Jan 2014 | A1 |
20140066901 | Dinger et al. | Mar 2014 | A1 |
20140066928 | Bennett et al. | Mar 2014 | A1 |
20140073858 | Sherwinter | Mar 2014 | A1 |
20140074065 | Muni et al. | Mar 2014 | A1 |
20140074140 | Johnson et al. | Mar 2014 | A1 |
20140074141 | Johnson et al. | Mar 2014 | A1 |
20140088498 | Stevens et al. | Mar 2014 | A1 |
20140094733 | Clopp et al. | Apr 2014 | A1 |
20140107404 | Gruber | Apr 2014 | A1 |
20140107427 | Chow et al. | Apr 2014 | A1 |
20140114233 | Deem et al. | Apr 2014 | A1 |
20140135587 | Hess | May 2014 | A1 |
20140144443 | Djupesland et al. | May 2014 | A1 |
20140163072 | Romon-de-Jesus | Jun 2014 | A1 |
20140180328 | Vaccaro et al. | Jun 2014 | A1 |
20140200443 | Chang et al. | Jul 2014 | A1 |
20140200444 | Kim et al. | Jul 2014 | A1 |
20140213968 | Vaccaro et al. | Jul 2014 | A1 |
20140218904 | Cayton | Aug 2014 | A1 |
20140238398 | Christopher et al. | Aug 2014 | A1 |
20140242064 | Morriss et al. | Aug 2014 | A1 |
20140243792 | Berman et al. | Aug 2014 | A1 |
20140243793 | Morriss et al. | Aug 2014 | A1 |
20140243876 | Suehara | Aug 2014 | A1 |
20140276624 | Jeppson | Sep 2014 | A1 |
20140276626 | Jenkins et al. | Sep 2014 | A1 |
20140276627 | Jenkins et al. | Sep 2014 | A1 |
20140277072 | Suehara | Sep 2014 | A1 |
20140288623 | Levin | Sep 2014 | A1 |
20140295728 | Cayton | Oct 2014 | A1 |
20140296898 | Chang et al. | Oct 2014 | A1 |
20140324093 | Chang et al. | Oct 2014 | A1 |
20140330074 | Morriss et al. | Nov 2014 | A1 |
20140336575 | Muni et al. | Nov 2014 | A1 |
20140336693 | Goldfarb et al. | Nov 2014 | A1 |
20140336694 | Becker | Nov 2014 | A1 |
20140350520 | Drontle et al. | Nov 2014 | A1 |
20150038901 | Lampropoulos et al. | Feb 2015 | A1 |
20150039014 | Schaeffer et al. | Feb 2015 | A1 |
20150045825 | Caplan et al. | Feb 2015 | A1 |
20150065872 | Drake et al. | Mar 2015 | A1 |
20150065995 | Sanchez et al. | Mar 2015 | A1 |
20150141819 | Linden et al. | May 2015 | A1 |
20150141915 | Lampropoulos et al. | May 2015 | A1 |
20150164309 | Chandler et al. | Jun 2015 | A1 |
20150164571 | Saadat | Jun 2015 | A1 |
20150173592 | Leeflang et al. | Jun 2015 | A1 |
20150174406 | Lamensdorf et al. | Jun 2015 | A1 |
20150196735 | Olig et al. | Jul 2015 | A1 |
20150196753 | Levin | Jul 2015 | A1 |
20150230700 | Chandler et al. | Sep 2015 | A1 |
20150258315 | Chandler et al. | Sep 2015 | A1 |
20150352341 | Chandler et al. | Dec 2015 | A1 |
20160008017 | Makower et al. | Jan 2016 | A1 |
20160135671 | Chandler et al. | May 2016 | A1 |
20160271375 | Chandler et al. | Sep 2016 | A1 |
20170246434 | Chandler et al. | Aug 2017 | A1 |
20180042471 | Chandler et al. | Feb 2018 | A1 |
20180333564 | Chandler et al. | Nov 2018 | A1 |
20190091450 | Chandler et al. | Mar 2019 | A1 |
Number | Date | Country |
---|---|---|
2266958 | Oct 1999 | CA |
2522386 | Nov 2012 | EP |
2522586 | Nov 2012 | EP |
1 988 953 | Jul 2017 | EP |
2 397 025 | Jul 2004 | GB |
2 397 243 | Jul 2004 | GB |
2 402 886 | Dec 2004 | GB |
2 403 154 | Dec 2004 | GB |
2 404 867 | Feb 2005 | GB |
2 405 350 | Mar 2005 | GB |
2 405 800 | Mar 2005 | GB |
2 414 414 | Nov 2005 | GB |
20050117277 | Dec 2005 | KR |
1020050117277 | Apr 2006 | KR |
1020120013930 | Feb 2012 | KR |
2002005703 | Jan 2002 | WO |
2002007632 | Jan 2002 | WO |
2006020180 | Feb 2006 | WO |
2010078145 | Jul 2010 | WO |
2012123819 | Sep 2012 | WO |
2015095214 | Jun 2015 | WO |
2015095214 | Jun 2015 | WO |
WO-2016108055 | Jul 2016 | WO |
Entry |
---|
Agro, et al., “Lightwand intubation using the Trachlight(TM): a brief review of current knowledge,” Canadian Journal of Anesthesia, (2000), pp. 592-599. |
Borris, et al., “Intraoperative nasal transillumination for maxillary sinus augmentation procedures: A technical note,” International Journal of Oral and Maxillofacial Implants, vol. 13, Issue 4 (Jul.-Aug. 1998), pp. 569-570 (abstract only). |
Friedman, et al., “Intraoperative and Postoperative Assessment of Frontal Sinus Patency by Transillumination,” The Laryngoscope, vol. 110 (Apr. 2000), pp. 683-684. |
Hung, et al., “Lightwand intubation: II—Clinical trial of a new lightwand for tracheal intubation in patients with difficult airways,” Canadian Journal of Anaesthesia, vol. 42, Issue 9 (1995), pp. 826-830. |
Massengill, “An Objective Technique for Submucous Cleft Palate Detection,” Plastic and Reconstructive Surgery, vol. 37, No. 4 (1966), pp. 355-359. |
Miyazaki, et al., “Fiberscopic Methods for Assessment of Velopharyngeal Closure during Various Activities,” presented at the 15th annual convention of the Japan Society of Oral Surgery in Nagoya, Oct. 1970; presented at the 25th annual convention of the Japan Society of Oral Medicine in Tokyo, Apr. 1971; and presented at the 2nd International Cleft Palate Congress in Copenhagen, Aug. 1973. |
U.S. Appl. No. 14/298,521 entitled Method of Performing a Sphenopalatine Ganglion—Block Procedure, filed Jun. 6, 2014. |
U.S. Appl. No. 14/572,353 entitled Surgical Device for Performing a Sphenopalatine Ganglion Block Procedure, filed Dec. 16, 2014. |
U.S. Appl. No. 14/712,722 entitled Method of Performing a Sphenopalatine Ganglion Block Procedure, filed May 14, 2015. |
U.S. Appl. No. 15/008,115 entitled Method of Performing a Sphenopalatine Ganglion Block Procedure, filed Jan. 27, 2016. |
U.S. Appl. No. 29/512,059 entitled Surgical Device, filed Dec. 16, 2014, 2015. |
International Preliminary Report on Patentability for International Application No. PCT/US2014/070642 dated Apr. 9, 2015—12 pages. |
International Search Report (ISR) for International Application No. PCT/US2014/070642 dated Apr. 9, 2015—3 pages. |
Written Opinion of the International Searching Authority for International Application No. PCT/US2014/070642 dated Apr. 9, 2015—11 pages. |
Cohen, et. al., “Transnasal Illumination to Guide the Craniofacial Resection of Anterior Skull Based Neoplasms,” Surgical Neurology, vol. 40 (1993), pp. 420-423. |
Dolor, et. al., “Management of Rhinosinusitis in Adults: Clinical Applications of Recent Evidence and Treatment Recommendations,” Journal of Clinical Outcomes Management, vol. 9, No. 8 (Aug. 2002), pp. 463-476. |
Felisati, “Headache & Migraine; Sphenopalatine endoscopic ganglion block alleviates cluster headache symptoms,” Life Science Weekly (Oct. 10, 2006), pp. 741. |
Petroianu, et. al., “Intubation with Transillumination: Nasal or Oral?” Prehospital and Disaster Medicine, vol. 14, No. 2 (Apr.-Jun. 1999), pp. 72-73. |
WelchAllyn Pocketscopes, Operating Instruction Manual, circa 2000. |
WelchAllyn 3.5v Transilluminators product brochure, circa 2000. |
Number | Date | Country | |
---|---|---|---|
62691010 | Jun 2018 | US | |
62782889 | Dec 2018 | US | |
62782898 | Dec 2018 | US |